TCR2

TCR2 develops and commercializes T cell receptor therapies for the treatment of hematological malignancies and solid tumors.

Business Model:

Revenue: $0

Employees: 51-200

Detailed TCR2 Information

Geographic Data

TCR2 headquarters map

Address: 100 Binney Street

City: Cambridge

State: MA

Zip: 02142

Country: US

Financial Info

Stage:

series b

Raised Last:

$125M

Raised Total:

$173M

Metrics

4,750,902Website Global Rank

1,823Website Monthly Traffic

Twitter Followers

Description

TCR2 develops and commercializes T cell receptor therapies for the treatment of hematological malignancies and solid tumors.

Contact Phone:
+16179495200

Contact Email:

TCR2 went public on 2/13/2019 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
2/13/2019

IPO Valuation:
$348M

Ticker Symbol:
TCRR

IPO Price:
$15/share

Amount Raised:
$75M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research